World's Best Scientists 2026 revealed!
VIEW LIST
Roberto Labianca

D-Index & Metrics

Discipline name D-Index World Ranking Current World Ranking National Ranking Current National Ranking Publications Citations
Medicine 91 11526 10837 430 411 487 48356

Roberto Labianca publications per year

The chart shows the history of publications by Roberto Labianca between 1977 and 2025, highlighting the no. of papers published in each year and offering an overview of the publication velocity of this scholar. Roberto Labianca published across 49 years, from 1977 to 2025, averaging 10.2 papers a year. Output peaked at 32 publications in 2008. 10 of the 500 publications appeared in the last two years.

No. of publications
10 20 30
Bar chart. Horizontal axis: year, 1977 to 2025. Vertical axis: number of publications, 0 to 32. Peak 32 publications in 2008. 1977: 1 publication 1978: 0 publications 1979: 1 publication 1980: 2 publications 1981: 0 publications 1982: 2 publications 1983: 1 publication 1984: 0 publications 1985: 0 publications 1986: 0 publications 1987: 2 publications 1988: 1 publication 1989: 0 publications 1990: 1 publication 1991: 5 publications 1992: 2 publications 1993: 7 publications 1994: 5 publications 1995: 7 publications 1996: 4 publications 1997: 10 publications 1998: 12 publications 1999: 11 publications 2000: 6 publications 2001: 13 publications 2002: 11 publications 2003: 12 publications 2004: 25 publications 2005: 17 publications 2006: 20 publications 2007: 30 publications 2008: 32 publications 2009: 22 publications 2010: 23 publications 2011: 17 publications 2012: 29 publications 2013: 15 publications 2014: 16 publications 2015: 27 publications 2016: 14 publications 2017: 24 publications 2018: 12 publications 2019: 10 publications 2020: 20 publications 2021: 11 publications 2022: 6 publications 2023: 4 publications 2024: 5 publications 2025: 5 publications
1977 2025

500 publications in total across all disciplines

View publications per year as a table
Roberto Labianca: publications per year, 1977 to 2025
Year Publications
1977 1
1978 0
1979 1
1980 2
1981 0
1982 2
1983 1
1984 0
1985 0
1986 0
1987 2
1988 1
1989 0
1990 1
1991 5
1992 2
1993 7
1994 5
1995 7
1996 4
1997 10
1998 12
1999 11
2000 6
2001 13
2002 11
2003 12
2004 25
2005 17
2006 20
2007 30
2008 32
2009 22
2010 23
2011 17
2012 29
2013 15
2014 16
2015 27
2016 14
2017 24
2018 12
2019 10
2020 20
2021 11
2022 6
2023 4
2024 5
2025 5
Total 500
Download as CSV

Roberto Labianca publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Roberto Labianca sits on this spectrum.

No. of scientists
200 400 600 800
Bar chart with 86 bars. Horizontal axis: publications, 101–120 to 1,796+. Vertical axis: number of scientists, 0 to 922. Most scientists, 922, have 341–360 publications. The last bar groups every scientist with 1,796 publications or more. The highlighted bar, 481–500 publications, is where this scientist sits. 101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 610 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101–120 publications 1,796+

This scientist: 487 publications — 56th percentile

56% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

View publications distribution as a table
Number of Medicine scientists by publication count, Research.com 2026 ranking edition. Based on 20,134 ranked scientists.
Publications Scientists This scientist
101–120 5
121–140 26
141–160 73
161–180 155
181–200 230
201–220 363
221–240 487
241–260 545
261–280 722
281–300 768
301–320 834
321–340 895
341–360 922
361–380 838
381–400 861
401–420 918
421–440 806
441–460 771
461–480 751
481–500 713 487
501–520 617
521–540 610
541–560 537
561–580 504
581–600 509
601–620 396
621–640 386
641–660 371
661–680 340
681–700 336
701–720 307
721–740 259
741–760 230
761–780 228
781–800 217
801–820 204
821–840 186
841–860 177
861–880 155
881–900 139
901–920 145
921–940 116
941–960 133
961–980 91
981–1,000 96
1,001–1,020 77
1,021–1,040 70
1,041–1,060 63
1,061–1,080 77
1,081–1,100 49
1,101–1,120 54
1,121–1,140 49
1,141–1,160 51
1,161–1,180 35
1,181–1,200 39
1,201–1,220 26
1,221–1,240 37
1,241–1,260 36
1,261–1,280 27
1,281–1,300 32
1,301–1,320 28
1,321–1,340 17
1,341–1,360 30
1,361–1,380 28
1,381–1,400 17
1,401–1,420 21
1,421–1,440 15
1,441–1,460 12
1,461–1,480 12
1,481–1,500 18
1,501–1,520 14
1,521–1,540 17
1,541–1,560 15
1,561–1,580 6
1,581–1,600 2
1,601–1,620 12
1,621–1,640 11
1,641–1,660 8
1,661–1,680 5
1,681–1,700 5
1,701–1,720 10
1,721–1,740 12
1,741–1,760 14
1,761–1,780 6
1,781–1,795 5
1,796+ 100
Download as CSV

Roberto Labianca D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Roberto Labianca sits on this spectrum.

No. of scientists
250 500 750 1,000
Bar chart with 75 bars. Horizontal axis: D-Index, 70–71 to 217+. Vertical axis: number of scientists, 0 to 1,027. Most scientists, 1,027, have 82–83 D-Index. The last bar groups every scientist with 217 D-Index or more. The highlighted bar, 90–91 D-Index, is where this scientist sits. 70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 399 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70–71 D-Index 217+

This scientist: 91 D-Index — 43rd percentile

43% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

View D-Index distribution as a table
Number of Medicine scientists by D-index, Research.com 2026 ranking edition. Based on 20,134 ranked scientists.
D-Index Scientists This scientist
70–71 226
72–73 391
74–75 574
76–77 730
78–79 891
80–81 972
82–83 1,027
84–85 1,003
86–87 960
88–89 970
90–91 922 91
92–93 839
94–95 808
96–97 779
98–99 668
100–101 611
102–103 630
104–105 513
106–107 541
108–109 445
110–111 429
112–113 399
114–115 393
116–117 318
118–119 302
120–121 287
122–123 255
124–125 256
126–127 252
128–129 230
130–131 179
132–133 168
134–135 163
136–137 159
138–139 134
140–141 134
142–143 118
144–145 109
146–147 106
148–149 74
150–151 79
152–153 80
154–155 87
156–157 57
158–159 74
160–161 69
162–163 60
164–165 53
166–167 39
168–169 42
170–171 32
172–173 39
174–175 40
176–177 28
178–179 19
180–181 23
182–183 31
184–185 18
186–187 20
188–189 22
190–191 13
192–193 21
194–195 12
196–197 12
198–199 14
200–201 15
202–203 13
204–205 10
206–207 8
208–209 4
210–211 12
212–213 11
214–215 10
216 4
217+ 98
Download as CSV

Overview

Roberto Labianca is affiliated with the Mario Negri Institute for Pharmacological Research in Italy. Their research primarily centers on medical topics with a strong focus on oncology, particularly colorectal cancer treatments and studies.

The primary areas of study for Roberto Labianca include:

  • Medicine
  • Oncology
  • Pulmonary and Respiratory Medicine
  • Pathology and Forensic Medicine
  • Surgery
  • Cancer Research

Within these fields, notable topics of work cover:

  • Colorectal Cancer Treatments and Studies
  • Colorectal Cancer Surgical Treatments
  • Gastric Cancer Management and Outcomes
  • Genetic factors in colorectal cancer
  • Venous Thromboembolism Diagnosis and Management
  • Colorectal and Anal Carcinomas
  • Cancer Genomics and Diagnostics

Roberto Labianca has contributed extensively to several scientific journals. Frequent publication venues include:

  • Journal of Clinical Oncology
  • Annals of Oncology
  • European Journal of Cancer
  • JAMA Oncology
  • Cancers

Their recent papers reflect a focus on clinical oncology and treatment protocols with works such as:

  • Localised colon cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up (2020, Annals of Oncology)
  • Effect of duration of adjuvant chemotherapy for patients with stage III colon cancer (IDEA collaboration): final results from a prospective, pooled analysis of six randomised, phase 3 trials (2020, The Lancet Oncology)
  • Duration of Adjuvant Doublet Chemotherapy (3 or 6 months) in Patients With High-Risk Stage II Colorectal Cancer (2021, Journal of Clinical Oncology)
  • Fluorouracil and dose-dense adjuvant chemotherapy in patients with early-stage breast cancer (GIM2): end-of-study results from a randomised, phase 3 trial (2022, The Lancet Oncology)
  • Prognostic Impact of Early Treatment and Oxaliplatin Discontinuation in Patients With Stage III Colon Cancer: An ACCENT/IDEA Pooled Analysis of 11 Adjuvant Trials (2022, Journal of Clinical Oncology)

Collaboration appears significant in their work, with frequent co-authors including:

  • Sara Lonardi
  • Timothy Iveson
  • Julien Taïeb
  • Alberto Sobrero
  • Takayuki Yoshino

Best Publications

  • ESMO consensus guidelines for the management of patients with metastatic colorectal cancer

    E. Van Cutsem;A. Cervantes;R. Adam;A. Sobrero

  • ESMO Consensus Guidelines for management of patients with colon and rectal cancer. A personalized approach to clinical decision making

    H J Schmoll;E Van Cutsem;A Stein;V Valentini

  • Defective Mismatch Repair As a Predictive Marker for Lack of Efficacy of Fluorouracil-Based Adjuvant Therapy in Colon Cancer

    Daniel J. Sargent;Silvia Marsoni;Genevieve Monges;Stephen N. Thibodeau

  • Early colon cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

    R. Labianca;B. Nordlinger;G. D. Beretta;S. Mosconi

  • Pooled analysis of fluorouracil-based adjuvant therapy for stage II and III colon cancer: who benefits and by how much?

    Sharlene Gill;Charles L. Loprinzi;Daniel J. Sargent;Stephan D. Thomé

  • Randomised trial of irinotecan versus fluorouracil by continuous infusion after fluorouracil failure in patients with metastatic colorectal cancer

    Philippe Rougier;Eric Van Cutsem;Emilio Bajetta;Norbert Niederle

  • Gemcitabine in Combination With Oxaliplatin Compared With Gemcitabine Alone in Locally Advanced or Metastatic Pancreatic Cancer: Results of a GERCOR and GISCAD Phase III Trial

    Christophe Louvet;R. Labianca;P. Hammel;G. Lledo

  • A pooled analysis of adjuvant chemotherapy for resected colon cancer in elderly patients.

    Daniel J. Sargent;Richard M. Goldberg;Stacy D. Jacobson;John S. Macdonald

  • Prognostic role of KRAS and BRAF in stage II and III resected colon cancer: results of the translational study on the PETACC-3, EORTC 40993, SAKK 60-00 trial.

    Arnaud D. Roth;Sabine Tejpar;Mauro Delorenzi;Pu Yan

  • Duration of Adjuvant Chemotherapy for Stage III Colon Cancer

    Axel Grothey;Alberto F. Sobrero;Anthony F. Shields;Takayuki Yoshino

  • Disease-Free Survival Versus Overall Survival As a Primary End Point for Adjuvant Colon Cancer Studies: Individual Patient Data From 20,898 Patients on 18 Randomized Trials

    Daniel J. Sargent;Harry S. Wieand;Daniel G. Haller;Richard Gray

  • Nadroparin for the prevention of thromboembolic events in ambulatory patients with metastatic or locally advanced solid cancer receiving chemotherapy: a randomised, placebo-controlled, double-blind study

    Giancarlo Agnelli;Gualberto Gussoni;Carlo Bianchini;Melina Verso

  • Evidence for Cure by Adjuvant Therapy in Colon Cancer: Observations Based on Individual Patient Data From 20,898 Patients on 18 Randomized Trials

    Daniel Sargent;Alberto Sobrero;Axel Grothey;Michael J. O'Connell

  • Adjuvant Chemotherapy After Potentially Curative Resection of Metastases From Colorectal Cancer: A Pooled Analysis of Two Randomized Trials

    Emmanuel Mitry;Anthony L.A. Fields;Harry Bleiberg;Roberto Labianca

  • Palonosetron improves prevention of chemotherapy-induced nausea and vomiting following moderately emetogenic chemotherapy: results of a double-blind randomized phase III trial comparing single doses of palonosetron with ondansetron

    R. Gralla;M. Lichinitser;S. Van der Vegt;H. Sleeboom

  • Impact of Chemoradiotherapy After Disease Control With Chemotherapy in Locally Advanced Pancreatic Adenocarcinoma in GERCOR Phase II and III Studies

    Florence Huguet;Thierry André;Pascal Hammel;Pascal Artru

  • DNA Mismatch Repair Status and Colon Cancer Recurrence and Survival in Clinical Trials of 5-Fluorouracil-Based Adjuvant Therapy

    Frank A. Sinicrope;Nathan R. Foster;Stephen N. Thibodeau;Silvia Marsoni

  • Randomized phase III trial comparing biweekly infusional fluorouracil/leucovorin alone or with irinotecan in the adjuvant treatment of stage III colon cancer: PETACC-3.

    Eric Van Cutsem;Roberto Labianca;György Bodoky;Carlo Barone

  • Meta-analysis of randomized trials: evaluation of benefit from gemcitabine-based combination chemotherapy applied in advanced pancreatic cancer

    Volker Heinemann;Stefan Boeck;Axel Hinke;Roberto Labianca

  • Erlotinib versus docetaxel as second-line treatment of patients with advanced non-small-cell lung cancer and wild-type EGFR tumours (TAILOR): a randomised controlled trial

    Marina Chiara Garassino;Olga Martelli;Massimo Broggini;Gabriella Farina

Frequent Co-Authors

Sandro Barni
Sandro Barni Mario Negri Institute for Pharmacological Research
Stefano Cascinu
Stefano Cascinu Vita-Salute San Raffaele University
Valter Torri
Valter Torri Mario Negri Institute for Pharmacological Research
Daniel J. Sargent
Daniel J. Sargent Mayo Clinic
Mario Mandalà
Mario Mandalà European Institute of Oncology
Sara Lonardi
Sara Lonardi Istituto Oncologico Veneto
Axel Grothey
Axel Grothey University of Tennessee at Knoxville
Thierry André
Thierry André Université Paris Cité
Armando Santoro
Armando Santoro Humanitas University
David Cunningham
David Cunningham Royal Marsden NHS Foundation Trust

External Links

Personal website of Roberto Labianca

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing a career in medicine doesn’t always begin with a traditional medical degree. There are many flexible, online alternatives that open doors into healthcare. For those eager to join the workforce quickly, accelerated lpn programs offer a faster route to becoming a Licensed Practical Nurse, combining convenience with solid job prospects.

Mental health professions are also in high demand. The shortest pmhnp program options allow registered nurses to advance their qualifications in psychiatric mental health, often in less time than traditional tracks.

Not all critical healthcare roles are clinical. Many students are turning to online healthcare administration programs to build careers in management, policy, and healthcare operations. Those seeking advanced roles can pursue affordable online mha programs, which can be completed entirely online and prepare graduates for leadership positions.

These diverse online degree pathways ensure you can find a study option that matches your timeline, budget, and career goals within the vast field of healthcare.

Best Scientists Citing Roberto Labianca

Bengt Glimelius

Bengt Glimelius

Uppsala University

Publications: 116

David Cunningham

David Cunningham

Royal Marsden NHS Foundation Trust

Publications: 116

Thierry André

Thierry André

Université Paris Cité

Publications: 107

Daniel J. Sargent

Daniel J. Sargent

Mayo Clinic

Publications: 96

Richard M. Goldberg

Richard M. Goldberg

West Virginia University

Publications: 95

Stefano Cascinu

Stefano Cascinu

Vita-Salute San Raffaele University

Publications: 78

Eric Van Cutsem

Eric Van Cutsem

KU Leuven

Publications: 77

Axel Grothey

Axel Grothey

University of Tennessee at Knoxville

Publications: 77

Josep Tabernero

Josep Tabernero

Vall d´Hebron Institute of Oncology

Publications: 74

Alfredo Falcone

Alfredo Falcone

University of Pisa

Publications: 71

Al B. Benson

Al B. Benson

Northwestern University

Publications: 70

Leonard Saltz

Leonard Saltz

Memorial Sloan Kettering Cancer Center

Publications: 69

Marc Buyse

Marc Buyse

Hasselt University

Publications: 67

Nancy E. Kemeny

Nancy E. Kemeny

Memorial Sloan Kettering Cancer Center

Publications: 64

Julien Taieb

Julien Taieb

Université Paris Cité

Publications: 61

Alok A. Khorana

Alok A. Khorana

Cleveland Clinic

Publications: 61

Trending Scientists

Arun Majumdar

Arun Majumdar

Stanford University

Christos G. Aneziris

Christos G. Aneziris

TU Bergakademie Freiberg

Maija Wessman

Maija Wessman

University of Helsinki

Jero Ahola

Jero Ahola

Lappeenranta University of Technology

Hei Wong

Hei Wong

City University of Hong Kong

Daniel J. Taylor

Daniel J. Taylor

University of Arizona

Charlotte Scheutz

Charlotte Scheutz

Technical University of Denmark

Maria De Angelis

Maria De Angelis

University of Bari Aldo Moro

George A. Barnett

George A. Barnett

University of California, Davis

Monideepa Tarafdar

Monideepa Tarafdar

University of Massachusetts Amherst

Zhijin Qin

Zhijin Qin

Tsinghua University

Ephraim Zehavi

Ephraim Zehavi

Bar-Ilan University

Harlan M. Krumholz

Harlan M. Krumholz

Yale University

Michael B. Farnell

Michael B. Farnell

Mayo Clinic

Bart W. Koes

Bart W. Koes

Erasmus University Rotterdam

Tapio Visakorpi

Tapio Visakorpi

Tampere University

Related Medicine Rankings & Guides

2027 Best Online Nursing Programs in Texas – Accredited RN to BSN Programs

2027 Best Online Nursing Programs in Texas – Accredited RN to BSN Programs
2027 Fastest Online Graduate Certificate Nurse Midwifery Programs

2027 Fastest Online Graduate Certificate Nurse Midwifery Programs
2027 Easiest RN-to-MSN Online Programs to Get Into

2027 Easiest RN-to-MSN Online Programs to Get Into
2027 Best Online CAHIIM-Accredited Health Information Management Degree Programs

2027 Best Online CAHIIM-Accredited Health Information Management Degree Programs
2027 Fastest Online MSN in Nurse Midwifery Programs

2027 Fastest Online MSN in Nurse Midwifery Programs
2027 Medical Billing and Coding Certificate vs. Bachelor's Degree: Explaining the Difference

2027 Medical Billing and Coding Certificate vs. Bachelor's Degree: Explaining the Difference
2027 Best Nurse Practitioner Programs in Utah – Accredited Schools Online & Campus

2027 Best Nurse Practitioner Programs in Utah – Accredited Schools Online & Campus
September 2027 Best Online Kinesiology Programs

September 2027 Best Online Kinesiology Programs
2027 Most Affordable CNA to RN Online Bridge Programs

2027 Most Affordable CNA to RN Online Bridge Programs
2027 Most Affordable Master’s Degrees in Healthcare Administration

2027 Most Affordable Master’s Degrees in Healthcare Administration
2027 Easiest Nurse Midwife Programs to Get Into

2027 Easiest Nurse Midwife Programs to Get Into
2027 Most Affordable Online DNP Programs

2027 Most Affordable Online DNP Programs
2027 Most Affordable Online Medical Billing and Coding Courses

2027 Most Affordable Online Medical Billing and Coding Courses
2027 Fastest Online MSN in Forensic Nursing Programs

2027 Fastest Online MSN in Forensic Nursing Programs
2027 Best PharmD Accelerated Degree Programs

2027 Best PharmD Accelerated Degree Programs
2027 Best Online Master’s in Clinical Research Programs

2027 Best Online Master’s in Clinical Research Programs
2027 Most Affordable Online LVN Programs

2027 Most Affordable Online LVN Programs
2027 Best Online DNP Programs

2027 Best Online DNP Programs
2027 Easiest Radiology Programs to Get Into

2027 Easiest Radiology Programs to Get Into
2027 Best Nurse Practitioner Programs in Maryland – Accredited Schools Online & Campus

2027 Best Nurse Practitioner Programs in Maryland – Accredited Schools Online & Campus
2027 Fastest Online Surgical Tech Certificate Programs

2027 Fastest Online Surgical Tech Certificate Programs

Recently Published Articles

2027 Is a 2-Year Game Programming Degree Worth It: Accelerated Bachelor's ROI & Time Trade-Offs

2027 Is a 2-Year Game Programming Degree Worth It: Accelerated Bachelor's ROI & Time Trade-Offs
2027 How to Become a Preschool Teacher Assistant in Michigan: Requirements & Certification

2027 How to Become a Preschool Teacher Assistant in Michigan: Requirements & Certification
2027 Fastest Online Biochemistry Degree Programs You Can Finish in Under 2 Years

2027 Fastest Online Biochemistry Degree Programs You Can Finish in Under 2 Years
2027 Different Types of Accounting Degrees and Their Salaries

2027 Different Types of Accounting Degrees and Their Salaries
2027 Indiana Wesleyan University Transfer Credit Policy: How Many Credits Can You Bring?

2027 Indiana Wesleyan University Transfer Credit Policy: How Many Credits Can You Bring?
2027 Medical Assistant vs. Dental Assistant: Explaining the Difference

2027 Medical Assistant vs. Dental Assistant: Explaining the Difference
2027 Fastest Online Forensic Science Master's Degree Programs You Can Finish in Under 2 Years

2027 Fastest Online Forensic Science Master's Degree Programs You Can Finish in Under 2 Years
2027 What Do You Learn in a Game Design Degree: Curriculum, Skills & Core Competencies

2027 What Do You Learn in a Game Design Degree: Curriculum, Skills & Core Competencies
2027 Best Online Master's in Management Information Systems for ERP and Systems Leadership

2027 Best Online Master's in Management Information Systems for ERP and Systems Leadership
2027 Best Online MBA Programs for Military & Veterans

2027 Best Online MBA Programs for Military & Veterans
2027 Different Types of Geographic Information Systems Degrees and Their Salaries

2027 Different Types of Geographic Information Systems Degrees and Their Salaries
2027 Best Online Adult Gerontology Primary Care Nurse Practitioner Degree Master's Programs for Career Changers

2027 Best Online Adult Gerontology Primary Care Nurse Practitioner Degree Master's Programs for Career Changers
2027 Is Demand for Social Psychology Degree Graduates Growing or Declining?

2027 Is Demand for Social Psychology Degree Graduates Growing or Declining?
2027 How to Become a Middle School Math Teacher in Illinois: Requirements & Certification

2027 How to Become a Middle School Math Teacher in Illinois: Requirements & Certification
2027 What Prerequisites Do You Need for a Social Media Marketing Degree? Entry Requirements, Credits & Eligibility Rules

2027 What Prerequisites Do You Need for a Social Media Marketing Degree? Entry Requirements, Credits & Eligibility Rules
2027 Cheapest Online Respiratory Care Therapy Master's Degrees That Pay Well: Tuition, Duration, and Earnings

2027 Cheapest Online Respiratory Care Therapy Master's Degrees That Pay Well: Tuition, Duration, and Earnings
2027 Highest-Paying PhD Degrees to Pursue

2027 Highest-Paying PhD Degrees to Pursue
2027 Grand Canyon University Online BS in Artificial Intelligence: Cost, Curriculum, Admissions, and Career Outcomes

2027 Grand Canyon University Online BS in Artificial Intelligence: Cost, Curriculum, Admissions, and Career Outcomes
2027 Best Cities for Nutrition Careers by Pay, Cost of Living, and Job Openings

2027 Best Cities for Nutrition Careers by Pay, Cost of Living, and Job Openings
2027 Most Affordable Online Legal Studies Degree Programs

2027 Most Affordable Online Legal Studies Degree Programs
2027 Online Nutrition Master's Curriculum Breakdown: Core Courses & Specializations

2027 Online Nutrition Master's Curriculum Breakdown: Core Courses & Specializations